Well, B+L Pharma has some concerns with another drain of talent to a competitor.
Many of us are getting calls and emails...
Many of us are getting calls and emails...
To Kala, or not to Kala
- Thread starter Debating
- Start date
-
- Tags
- None
Possible approval of a branded generic Loteprednol suspension, sold by a crew of primary care reps, most of whom are about to get put on PIPs... I think they know exactly what is coming
B+L is a joke. Let me state the obvious for you idiots. Inveltys 1% has a nice feature of being approved with a BID dosing. Does Inveltys 1% work as well as Pred Forte 1%? I do not know. Do physicians prescribe brand name steroids post-surgery? I do not know. My personal first choice would be Pred Forte. However, if Inveltys 1% worked just as well as Pred Forte, then I may use Inveltys 1% routinely. Notice that I did not mention Lotemax until now? Keep pushing Lotemax off-label for dry eye.
Why do I hate this B+L so much? Do you want to fuck-up a perfect glass of clean water? Give it to B+L, they will find a way to turn that clean water chunky brown.
Doesn’t sound like you are a good doctor! Plenty of “I do not know” responses when a knowledgeable Ophthalmologist or Optometrist would have answers to these BASIC questions. Even a crappy Pharma rep in Ophthalmology knows the reasons to prescribe Lotemax Gel or Lotemax SM vs Inveltys........or other branded therapies vs Inveltys. Nice try.
Inveltys is not the reason why people would go to Kala, it is the new Dry Eye product. Yet, working in a therapeutic class where Restasis, Cequa, Xiidra, and OTC lubricating drops compete maybe it isn’t the best place to be. Even for “flare ups” it is too crowded.
What are those reasons? BC NOBODY is using SM or Gel post op. You all are calling on docs for off label usage for dry eye bc nobody wants to use that mess post op (unless they are getting paid)
Oh yeah and another thing, stop moving the samples in my sample cabinets. Stop throwing away Inveltys and their coupons. I see you.
crowded doesn't begin to describe it. Just wait another 5 years and it will be like a can of sardines. Not to mention there will be a generic on the market and any new drug will take 2-3 years just to get full coverage. Look at xiidra and cequa, they still have no part D coverage.
Yes it is crowded and competitive, but if you are good at sales then you should thrive in the competition . B+L has many territories across the Nation even beating Durezol, so LSM is proving to be a great surgical drug.
Please, Lotamax, SM ,Gel and Inveltys are all clones of loteprednol been out for 25 years, all of this shit is old news. Compounding is crushing all of the cataract mkt. Dry eye is a crowded ,boring market to sell.Generic Restasis will dominate the market because it will be cheap. Anyone selling dry eye brands will encounter the same : crowded fields, no coverage . Dumb ass B&L will be out with their own version of this bs market again with high cost and no coverage.
Very true!
After searching bauScH health's websITe, I couldn’t find a section that discusses and shows their pipeline. I was able to find links to their board of directors, twice. I found a lot of useless information. A person interested in a career or a potential/current investor in bauScH would most certaInly appreciaTe the ease of quickly finding information about the company's pipeline on the company's website, right?
I am sure B+L has a few good products, but they certainly have a lot of garbage. If it is profitable garbage and you don't care about what you are selling or investing in, then this might be the right fit for you.
The B&l products are actually good BUT most are very old in the product life cycle. The one newer product : Vyzulta is a good product but completely mismanaged from it's very start by a session of dumb ass upper management decisions. I agree with a earlier post that the only thing that is in the pipeline is a dry eye drug that will be fighting for the crumbs between 4 other Branded dry eye products already out there. The vast majority of the Dry eye market will be dominated by generic Restasis.
An intangible asset might be worth more on paper than sales would equal from a product that resulted from the intangible asset.
You can't blame the current management team more than previous management teams. It isn't just the management teams either. R&D is and has been lacking at B+L for a really long time. Vyzulta is something new that resulted from other similar products in the market. So, let's pretend you get a new management team in place, how are they going to do things differently when the R&D team is shit?
B+L Retina, how does that compare to the competition?
For people claiming to be doing research you seem to be pretty shitty at it. It’s very easy to see what we have that is new in the retina space as well as in the dry eye space. Why don’t you actually “do” the research instead of “say” that you’re doing the research.
A quick google search and you will be done.
A quick google search and you will be done.
"As the global leader in surgical retina, Alcon represents not only quality and continuous improvement, but also an indispensable partner providing breakthrough technologies that can help you improve your patient outcomes and your practice."
B+L's retina website is impressive except for not claiming to be the global leader in surgical retina. There must be a reason for that. B+L retina not shit, but not the leader.
The Current management is as fucked up as the previous management,Vyzulta has had 4 product managers one as dumb as the other. The R& D is a Non factor and has been since the days of Valeant and that POS Pearson. The company is broke and running on Monopoly money ,It shows! Any product that B&L comes by is somebody's else's products be it retina or glaucoma.
just today I saw a dr who has written 5 Inveltys scrips in 3 months who had 25- yes 25 samples of Inveltys. He also had one LotemAx SM - glad I got to restock the shelf.
just today I saw a dr who has written 5 Inveltys scrips in 3 months who had 25- yes 25 samples of Inveltys. He also had one LotemAx SM - glad I got to restock the shelf.
"BC NOBODY is using SM or Gel post op. You all are calling on docs for off label usage for dry eye bc nobody wants to use that mess post op (unless they are getting paid)"